A blaVIM-2 plasmid disseminating in extensively drug-resistant clinical Pseudomonas aeruginosa and Serratia marcescens isolates

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 7017-7018

  Vilacoba, Elisabet ^a   Quiroga, Cecilia ^a   Pistorio, Mariano ^b   Famiglietti, Angela ^c   Rodríguez, Hernán ^c   Kovensky, Jaime ^d   Déraspe, Maxime ^e,f   Raymond, Frédéric ^e,f   Roy, Paul H ^e,f   Centrón, Daniela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d Ciudad Autónoma de Buenos Aires   (Argentina)

^e UNIVERSITÉ LAVAL   (Canada)

^f LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; BETA LACTAMASE; BETA-LACTAMASE BLA(VIM-2);

ANTIBIOTIC SENSITIVITY; ARGENTINA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLA VIM 2 GENE; DISK DIFFUSION; DNA ISOLATION; DNA LIBRARY; DNA PURIFICATION; DNA SEQUENCE; GENE CASSETTE; INDEL MUTATION; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PLASMID PDCPR1; PSEUDOMONAS AERUGINOSA; REPLICON; SERRATIA MARCESCENS; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECTS; GENETICS; HORIZONTAL GENE TRANSFER; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PSEUDOMONAS INFECTIONS; SERRATIA INFECTIONS;

BASE SEQUENCE; BETA-LACTAMASES; GENE TRANSFER, HORIZONTAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

EID: 84908428594     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02934-14     Document Type: Letter

References (11)

1. Savard P, Carroll KC, Wilson LE, Perl TM. 2013. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos. Infect. Control Hosp. Epidemiol. 34:730-739. http://dx.doi.org/10.1086/671003.
2. GIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother. 48:4654-4661. http://dx.doi.org/10.1128/AAC.48.12.4654-4661.2004.
3. Nastro M, Monge R, Zintgraff J, Vaulet LG, Boutureira M, Famiglietti A, Rodriguez CH. 2013. First nosocomial outbreak of VIM-16-producing Serratia marcescens in Argentina. Clin. Microbiol. Infect. 19:617-619. http://dx.doi.org/10.1111/j.1469-0691.2012.03978.x.
4. IMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin. Infect. Dis. 41:1549-1556. http://dx.doi.org/10.1086/497831.
5. NDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998-2001. http://dx.doi.org/10.1093/jac/dkr256.
6. Wachino J, Yoshida H, Yamane K, Suzuki S, Matsui M, Yamagishi T, Tsutsui A, Konda T, Shibayama K, Arakawa Y. 2011. SMB-1, a novel subclass B3 metallo-β-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 55:5143-5149. http://dx.doi.org/10.1128/AAC.05045-11.
7. VIM-2 from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 68:1060-1065. http://dx.doi.org/10.1093/jac/dks526.
8. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897. http://dx.doi.org/10.1128/AAC.44.4.891-897.2000.
9. Marchiaro PM, Brambilla L, Moran-Barrio J, Revale S, Pasteran F, Vila AJ, Viale AM, Limansky AS. 2014. The complete nucleotide sequence of the carbapenem resistance-conferring conjugative plasmid pLD209 from a Pseudomonas putida clinical strain reveals a chimeric design formed by modules derived from both environmental and clinical bacteria. Antimicrob. Agents Chemother. 58:1816-1821. http://dx.doi.org/10.1128/AAC.02494-13.
10. CLSI. 2014. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Boisvert S, Laviolette F, Corbeil J. 2010. Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies. J. Comput. Biol. 17:1519-1533. http://dx.doi.org/10.1089/cmb.2009.0238.